Does Thyroid Hormone Treatment Benefit Patients with Subclinical Hypothyroidism?
BACKGROUND AND PURPOSE:
Defined as elevated thyrotropin with normal range free thyroxine
More common in women
Often treated with thyroid hormone, especially if women present with symptoms related to fatigue, constipation or weight gain
Feller et al. (JAMA, 2018) sought to determine whether thyroid hormone therapy was associated with improvement in quality of life and thyroid-related symptoms in individuals with subclinical hypothyroidism
Systematic review and meta-analysis
Non-pregnant adults with subclinical hypothyroidism
Included RCTs that compared thyroid hormone therapy to
Two independent reviewers extracted data to avoid bias and quality of evidence was assessed with GRADE methods tool
Minimum follow-up of 3 months
Defined as a thyrotropin level above reference range in combination with a free thyroxine level within the reference range (center-specific reference ranges)
General quality of life
21 studies were included | 2192 patients were randomized
Duration of treatment ranged from 3-18 months
Thyroid hormone therapy lowered the mean thyrotropin value into the normal reference range compared with placebo
Thyroid treatment was not associated with
Benefit regarding general quality of life (95% CI, −0.25 to 0.03)
Thyroid-related symptoms (95% CI, −0.12 to 0.14)
Risk of bias was low | Quality of evidence assessed with the GRADE tool was judged moderate to high
Thyroid hormone therapy was not associated with improvements in general quality of life or thyroid-related symptoms in patients with subclinical hypothyroidism
The authors state
These findings do not support the routine use of thyroid hormone therapy in adults with subclinical hypothyroidism
OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Jointly provided by
NOT ENOUGH CME HOURS
It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan